The Recombinant Salmonella dublin Probable ubiquinone biosynthesis protein UbiB (ubiB) is a protein involved in the biosynthesis of ubiquinone, also known as coenzyme Q (CoQ), in bacteria. Ubiquinone plays a crucial role in the electron transport chain and is essential for energy production in cells. The UbiB protein is part of a larger family of proteins involved in CoQ biosynthesis and has been identified in various bacterial species, including Escherichia coli and Salmonella dublin.
UbiB is required for the first monooxygenase step in CoQ biosynthesis. This step involves the conversion of octaprenylphenol into a more complex intermediate that eventually leads to the formation of CoQ. In Escherichia coli, UbiB is encoded by the yigR gene and is part of an operon that includes ubiE and yigP genes, which are also essential for CoQ and menaquinone synthesis .
| Gene | Function in CoQ Biosynthesis |
|---|---|
| ubiE | C-methyltransferase for CoQ and menaquinone synthesis |
| yigP | Unknown specific role, part of the operon |
| ubiB (yigR) | First monooxygenase step in CoQ biosynthesis |
Recombinant UbiB proteins are produced using genetic engineering techniques where the ubiB gene is cloned into an expression vector and expressed in a suitable host organism. These proteins are used in various applications:
Research: To study the mechanisms of CoQ biosynthesis and its regulation.
Diagnostics: In ELISA kits for detecting antibodies or antigens related to UbiB.
Biotechnology: Potential applications in improving bacterial strains for biotechnological purposes.
| Application | Description |
|---|---|
| Research | Studying CoQ biosynthesis mechanisms |
| Diagnostics | ELISA kits for detecting UbiB-related antibodies or antigens |
| Biotechnology | Improving bacterial strains for industrial applications |
KEGG: sed:SeD_A4359
UbiB (identified as yigR in E. coli) is required for the first monooxygenase step in coenzyme Q (CoQ) biosynthesis . This protein plays a critical role in the electron transport chain by facilitating ubiquinone production, which is essential for aerobic respiration. In E. coli, ubiB is the third gene in an operon containing ubiE, yigP, and ubiB (yigR) . Disruption of this gene leads to an accumulation of octaprenylphenol, an intermediate in the CoQ biosynthesis pathway .
While direct evidence linking UbiB to S. Dublin virulence is limited in the provided literature, metabolic proteins often indirectly affect virulence. S. Dublin is known to cause both intestinal and systemic infections in cattle and presents a serious risk to human health . The bacterium's ability to produce energy efficiently through aerobic respiration (facilitated by UbiB) likely impacts its ability to colonize and persist within host tissues. Research on other Salmonella serovars suggests that deficiencies in energy metabolism can attenuate virulence.
The ubiB gene belongs to a predicted protein kinase family . In E. coli, it exists within an operon structure alongside ubiE (encoding a C-methyltransferase required for both CoQ and menaquinone synthesis) and yigP . Mutations affecting this operon can have polar effects on downstream genes, as demonstrated when an IS1 element insertion in ubiE affected ubiB expression in E. coli strain AN59 .
When designing experiments involving recombinant UbiB, researchers should implement:
Factorial designs that account for multiple variables and their interactions
Blocking to control for batch effects and other confounding variables
Adequate biological replicates (minimum of 5 per group is recommended)5
Balanced design with equivalent sample sizes across groups
Randomization to minimize bias
Appropriate controls for each experimental condition
Researchers should avoid common design pitfalls including:
Unbalanced designs (e.g., 20 samples in one group and 5 in another)
Inadequate control for batch effects
Confounding variables that cannot be separated in analysis
Incomplete factorial designs where important sources of variability are omitted5
Based on bacterial genetics principles, researchers should consider:
| Method | Advantages | Limitations |
|---|---|---|
| Allelic exchange | Chromosomal integration, native expression levels | Labor-intensive, strain-specific optimization required |
| Plasmid-based expression | Rapid implementation, control over expression levels | Plasmid stability issues, non-physiological expression |
| CRISPR-Cas9 genome editing | Precise modifications, no antibiotic markers required | Requires optimization of guide RNAs, PAM sites |
| Complementation studies | Functional validation, physiological relevance | Requires construction of clean deletion mutants |
Assessment should include:
Biochemical approaches:
Genetic approaches:
Complementation studies in ubiB mutant strains
Expression analysis using qRT-PCR and protein detection
Physiological approaches:
Growth kinetics under aerobic vs. anaerobic conditions
Oxygen consumption rates
Electron transport chain activity measurements
S. Dublin isolates have been found to harbor plasmids carrying antimicrobial resistance genes . A specific 49-kb IncN plasmid identified in Danish S. Dublin isolates carries resistance genes (blaTEM-1, tetA, strA, strB) and confers resistance to ampicillin, amoxicillin-clavulanic acid, and tetracycline . The relationship between core metabolism (including ubiquinone biosynthesis) and plasmid-mediated resistance warrants investigation, as energy-dependent mechanisms like efflux pumps require functional electron transport chains for optimal activity.
Recent global studies have shown increasing prevalence of antimicrobial resistance in S. Dublin, with resistant strains more likely to cause bloodstream infections, hospitalization, and death compared to susceptible strains .
S. Dublin has demonstrated remarkable persistence within cattle herds, with closely related isolates circulating within the same herd for over 20 years . While the specific contribution of UbiB to this persistence is not directly addressed in the provided literature, metabolic robustness is likely a contributing factor to long-term survival. Research has shown that Danish cattle isolates cluster in distinct geographical regions, suggesting adaptation to local conditions .
The metabolic versatility conferred by functional ubiquinone biosynthesis may contribute to S. Dublin's ability to persist in various microenvironments within hosts and farm settings.
Effective immune response against Salmonella requires both humoral and cell-mediated immunity, as the bacterium can survive within macrophages . The role of UbiB in this context includes:
Potentially influencing bacterial survival within phagocytes where respiratory metabolism may be critical
Possibly affecting expression of bacterial antigens recognized by the immune system
Potentially modulating bacterial responses to oxidative stress generated by immune cells
Vaccination strategies targeting S. Dublin must stimulate both antibody production and T cell responses, particularly those producing IFN-γ (Th1) and IL-17 (Th17), which are critical for controlling intracellular Salmonella .
When analyzing data from UbiB functional studies, researchers should:
For comparing multiple experimental groups:
Use ANOVA with appropriate post-hoc tests for parametric data
Consider non-parametric alternatives when assumptions are violated
Include relevant covariates using ANCOVA when appropriate
For time-course experiments:
Apply repeated measures analysis or mixed-effects models
Consider time series analysis for complex temporal patterns
For gene expression studies:
Use specialized statistical packages designed for RNA-seq or microarray data
Account for multiple testing corrections (FDR, Bonferroni)
For bacterial population studies:
When studying diverse S. Dublin isolates, researchers should consider:
Critical controls include:
Genetic controls:
Wild-type parent strain
Clean deletion mutant (ΔubiB)
Complemented strain (ΔubiB + ubiB)
Vector-only control for plasmid-based studies
Expression controls:
qRT-PCR to confirm transcription
Western blotting to verify protein production
Inclusion of tagged variants for detection (ensuring tags don't interfere with function)
Functional controls:
Experimental design controls:
Accounting for batch effects5
Including biological and technical replicates
Randomization and blinding where appropriate
CRISPR-Cas9 offers several advantages for UbiB research:
Creation of precise mutations to study structure-function relationships
Development of regulated expression systems to study dosage effects
Generation of reporter fusions to study localization and expression dynamics
Implementation of CRISPR interference (CRISPRi) for transient knockdown studies
Creation of comprehensive mutant libraries targeting UbiB domains
Given the essential role of ubiquinone in aerobic respiration, UbiB represents a potential target for antimicrobial development:
The increasing prevalence of antimicrobial resistance in S. Dublin (particularly in North American isolates ) necessitates novel therapeutic approaches
Metabolic targets may present higher barriers to resistance development
Targeting UbiB could potentially reduce bacterial persistence within host cells
Structure-based drug design could exploit differences between bacterial and host ubiquinone biosynthesis
Integration of multiple omics technologies could provide comprehensive insights: